Factorial Survey: Decision Making for Extracorporeal life support (ECLS)

Extracorporeal life support (ECLS) provides support to patients with cardiopulmonary failure refractory to conventional therapy. While ECLS is potentially life-saving, it is associated with severe complications; decision making to initiate ECLS must, therefore, carefully consider which patients ECLS potentially benefits despite its consequences. Data of a factorial survey among 420 physicians from 111 hospitals in Switzerland and Germany.

体外生命支持（Extracorporeal Life Support, ECLS）可为经传统治疗无效的心肺衰竭患者提供生命支持。尽管该技术具备潜在的挽救生命的价值，但常伴随严重并发症；因此，启动体外生命支持的临床决策必须审慎考量：即便该技术存在各类不良后果，仍需明确哪些患者可从ECLS中获益。本数据集来自一项针对瑞士与德国111家医院的420名医师开展的析因调查。